Mediclever Home Page

Drug and Medical Device Reimbursement Consultants.

Transparent, deliverable-based reimbursement consulting.

Need: Develop a reimbursable product

You already speak with physicians who may use or prescribe your product, and you plan to meet with the FDA and Europe's EMA or Notified Bodies to obtain feedback on your regulatory strategy. However, unless your drug or medical device will also be reimbursed, or paid for in any other way, it will be very difficult to commercialize it.

Since your current decisions impact the odds of obtaining reimbursement in the future, planning for the development of a reimbursable drug or a medical device should start now. > Make sure you develop a reimbursable product...

Solution: Our reimbursement process

We assume full responsibility for the entire process of obtaining reimbursement, funding or out-of-pocket payment - from start to finish.

This includes the development of a preliminary reimbursement strategy for each country, guidance through the development of your clinical data, as well as working with the local medical community in each country to successfully apply for new codes, appropriate payment rates and favorable coverage policies. > See our reimbursement process here...

Why Mediclever

We’ve successfully guided hundreds of life science clients from around the world in commercializing their medical devices, drugs and apps.

We cover 15 countries (see below) with our team of local experts, assembled according to each clients’ selected target markets and phase within the reimbursement process.

Based on our extensive experience, we provide our clients with a transparent flat-fee model, clear deliverables and set timelines. > Learn more about our unique reimbursement approach here...

Local Presence and Experience in:

  • Sweden
  • Austria
  • Denmark
  • Other
  • Australia
  • Israel